glp 1 patent expiration date pharmaindustry #glp1 #patentcliff #obesitytreatment #diabetescare #indianpharma #biologics A $60 billion industry just

Do try to diversify across proteins because theres just different vitamin and mineral profiles in different types of protein

That falls short of tirzepatide numbers but represents a significant health improvement for many people and may be the appropriate starting point before considering pharmaceutical options

doi: 10.1016/S0140-6736(19)31149-3 16 NorthEJNewmanJD

More recently, the use of IPI504 (Retaspimycin, a synthetic derivative of Geldanamycin), in an in vitro model of age-related macular degeneration (AMD) on senescent ARPE-19 (human arising retinal pigment epithelial cells), leads to a decrease of SA--Galactosidase positive cells, associated with a downregulation of senescence-associated gene expression as well as SASPs secretion, suggesting that in some cases HSP90 inhibitors could also be used as senomorphics 27